Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mullane

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Child and Adolescent Psychiatry and Mental Health|January 14, 2022
Western Australian adolescent emotional wellbeing during the COVID-19 pandemic in 2020H M Thomas, K C Runions, L Lester, et al.
The New England Journal of Medicine|May 9, 2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantationRoy F Chemaly, Andrew J Ullmann, Susanne Stoelben, et al.
Nature Medicine|February 11, 2022
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trialRolando Pajon, Yamuna D Paila, Bethany Girard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 12, 2021
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipientsKathleen A Linder, Christopher Kovacs, Kate M Mullane, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
The New England Journal of Medicine|December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
Histoplasmosis after solid organ transplantMaha Assi, Stanley Martin, L Joseph Wheat, et al.
Lancet (London, England)|June 2, 2018
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trialDrew J Winston, Kathleen M Mullane, Oliver A Cornely, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Child and Adolescent Psychiatry and Mental Health|January 14, 2022
Western Australian adolescent emotional wellbeing during the COVID-19 pandemic in 2020H M Thomas, K C Runions, L Lester, et al.
The New England Journal of Medicine|May 9, 2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantationRoy F Chemaly, Andrew J Ullmann, Susanne Stoelben, et al.
Nature Medicine|February 11, 2022
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trialRolando Pajon, Yamuna D Paila, Bethany Girard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 12, 2021
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipientsKathleen A Linder, Christopher Kovacs, Kate M Mullane, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
The New England Journal of Medicine|December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
Histoplasmosis after solid organ transplantMaha Assi, Stanley Martin, L Joseph Wheat, et al.
Lancet (London, England)|June 2, 2018
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trialDrew J Winston, Kathleen M Mullane, Oliver A Cornely, et al.
Pageof 12